Showing results (431-440 of 452) with videos related to

Sort By:
Pageof 46
Circulation|June 3, 2010
Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratioLuigi Di Biase, J David Burkhardt, Prasant Mohanty, et al.
Open Forum Infectious Diseases|December 3, 2021
Impact of Choice of Prophylaxis on the Microbiology of Cardiac Implantable Electronic Device Infections: Insights From the Prevention of Arrhythmia Device Infection Trial (PADIT)Yves Longtin, Philippe Gervais, David H Birnie, et al.
JAMA Network Open|August 27, 2021
Effect of Continuous Electrocardiogram Monitoring on Detection of Undiagnosed Atrial Fibrillation After Hospitalization for Cardiac Surgery: A Randomized Clinical TrialAndrew C T Ha, Subodh Verma, C David Mazer, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 28, 2025
Women with persistent atrial fibrillation need more than pulmonary vein isolation: personalised extra-pulmonary vein ablation strategy vs. pulmonary vein isolation alone in the TAILORED-AF trialIsabel Deisenhofer, Julien Seitz, Marie-Sophie Nguyen-Tu, et al.
The Canadian Journal of Cardiology|January 15, 2026
Current Challenges in Cardiac Device Management: Guidance for Practicing Clinicians: A Canadian Journal of Cardiology White PaperJacqueline Joza, Francois Philippon, Derek S Chew, et al.
Journal of the American College of Cardiology|December 7, 2019
Risk Factors for Infections Involving Cardiac Implanted Electronic DevicesDavid H Birnie, Jia Wang, Marco Alings, et al.
Journal of the American College of Cardiology|December 15, 2018
Prevention of Arrhythmia Device Infection Trial: The PADIT TrialAndrew D Krahn, Yves Longtin, François Philippon, et al.
JAMA Cardiology|April 5, 2023
Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With MortalityHui-Chen Han, Jia Wang, David H Birnie, et al.
European Heart Journal|September 2, 2024
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trialsRenate B Schnabel, Juan Benezet-Mazuecos, Nina Becher, et al.
The Canadian Journal of Cardiology|November 16, 2020
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial FibrillationJason G Andrade, Martin Aguilar, Clare Atzema, et al.
Pageof 46